Clinical and radiographic course of arrested cerebral adrenoleukodystrophy
- 16 June 2020
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 94 (24) , e2499-e2507
Abstract
Objective To gain insight into the natural history of arrested cerebral adrenoleukodystrophy (CALD) by quantifying the change in Neurologic Function Score (NFS) and Loes Score (LS) over time in patients whose cerebral lesions spontaneously stopped progressing. Methods We retrospectively reviewed a series of 22 patients with arrested CALD followed longitudinally over a median time of 2.4 years (0.7–17.0 years). Primary outcomes were change in radiographic disease burden (measured by LS) and clinical symptoms (measured by NFS) between patients who never developed a contrast-enhancing lesion (gadolinium enhancement (GdE)− subgroup) and those who did (GdE+ subgroup). Secondary analyses comparing patterns of neuroanatomic involvement and lesion number, and prevalence estimates, were performed. Results Cerebral lesions were first detected at a median age of 23.3 years (8.0–67.6 years) with an initial LS of 4 (0.5–9). NFS was 0.5 (0–6). Overall change in NFS or LS per year did not differ between subgroups. No patients who remained GdE− converted to a progressive CALD phenotype. The presence of contrast enhancement was associated with disease progression (rs = 0.559, p < 0.001). Four patients (18.2%) underwent step-wise progression, followed by spontaneous resolution of contrast enhancement and rearrest of disease. Three patients (13.6%) converted to progressive CALD. Nineteen patients (86.4%) had arrested CALD at the most recent follow-up. The prevalence of arrested CALD is 12.4%. Conclusion Arrested CALD lesions can begin in childhood, and patients are often asymptomatic early in disease. The majority of patients remain stable. However, clinical and MRI surveillance is recommended because a minority of patients undergo step-wise progression or conversion to progressive CALD.Keywords
This publication has 23 references indexed in Scilit:
- Hematopoietic cell transplantation does not prevent myelopathy in X‐linked adrenoleukodystrophy: a retrospective studyJournal of Inherited Metabolic Disease, 2014
- Hematopoietic Stem Cell Transplantation—50 Years of Evolution and Future PerspectivesRambam Maimonides Medical Journal, 2014
- Outcomes after allogeneic hematopoietic cell transplantation for childhood cerebral adrenoleukodystrophy: the largest single-institution cohort reportBlood, 2011
- Survival analysis of haematopoietic cell transplantation for childhood cerebral X-linked adrenoleukodystrophy: a comparison studyThe Lancet Neurology, 2007
- Cerebral X-linked adrenoleukodystrophy: the international hematopoietic cell transplantation experience from 1982 to 1999Blood, 2004
- X-Linked Adrenoleukodystrophy: Overview and Prognosis as a Function of Age and Brain Magnetic Resonance Imaging Abnormality. A Study Involving 372 PatientsNeuropediatrics, 2000
- Long-term effect of bone-marrow transplantation for childhood-onset cerebral X-linked adrenoleukodystrophyThe Lancet, 2000
- Arrested cerebral adrenoleukodystrophy: A clinical and proton magnetic resonance spectroscopy study in three patientsPediatric Neurology, 1996
- Adrenoleukodystrophy: Phenotypic variability and implications for therapyJournal of Inherited Metabolic Disease, 1992
- MRI detects cerebral involvement in neurologically asymptomatic patients with adrenoleukodystrophyNeurology, 1989